AB SCIEX Scientist Wins HUPO 2014 Science and Technology Award
News Oct 06, 2014
AB SCIEX announced that Dr. Subhasish “Babu” Purkayastha, Director, R&D at AB SCIEX, has been awarded the Human Proteome Organization (HUPO) Science and Technology Award for efforts in commercialization of isobaric labeling for protein quantification with the development of iTRAQ chemistries. The award further establishes AB SCIEX as an innovator in proteomics research as Dr. Purkayastha is the second AB SCIEX team member to be recognized by HUPO in the past two years. In 2013, Dr. Christie Hunter received the award for her contributions to the development and commercialization of a breakthrough approach for targeted proteomics. Dr. Purkayastha will be presented his award for his contribution to advancing proteomics at this year’s HUPO 2014 conference in Madrid.
The HUPO Science and Technology Award is presented for efforts to commercialize a technology, product or procedure, which makes the life of the proteomics researcher easier. Dr. Purkayastha has been a leader in enabling protein expression analysis, quantitation, and multiplexing by mass spectrometry. A key figure in the commercialization of breakthrough technologies such as ICAT, cleavable ICAT, and iTRAQ (both 4-plex and 8-plex), all of which have been enjoyed wide use, with over 1,000 publications, and acceptance in proteomics laboratories worldwide, Dr. Purkayastha has played a crucial role leading a collective vision bringing multiplexing to the market.
“Our team of chemists, software developers, MS application scientists and our partners are the reason why we are able to commercialize the first multiplex solution in 2004 so customers could recognize the benefits of multiplexing,” said Dr. Babu Purkayastha, Director of Reagent R&D at AB SCIEX. “We made it easy for scientists to adopt the technology and focus their research on advancing the knowledge of biology with more relevant data and consistent results. Our goal is to provide tools that help our customers to design and perform studies that address key biological questions such as identifying biomarkers that goes a long way in developing treatments and tests for diseases such as Alzheimer’s, Sepsis, and Cancer, among others.”
“AB SCIEX would like to congratulate Dr. Babu Purkayastha for receiving such a prestigious award from HUPO in recognition to his commitment and advancement to proteomics research with the development of iTRAQ,” said Veronique Berger, V.P. Marketing for AB SCIEX. We are honored to be associated with two of the most forward researchers in the proteomics industry in Dr. Purkayastha and Dr. Christie Hunter, HUPO’s 2013 recipient. ‘Answers for Science. Knowledge for Life.TM’ is about investing in innovative solutions that impact the proteomics industry so scientists can do what they do best, make a difference.”
Throughout the week at the HUPO WW congress in Madrid AB SCIEX will continue showcasing new innovations for Proteomics such as the HUPO announced OneOmics project, an exclusive partnership to bring together SWATH™ acquisition softwarebased next-generation proteomics (NGP) and next-generation sequencing (NGS) tools in a cloud computing environment. As well as the ASMS launched Next-generation Proteomics Platform including the new TripleTOF® 6600 system with SWATH™ 2.0 technology. In addition, scientists from the company will be demonstrating ways to accelerate and improve workflows on a variety of instruments.
About 422 million people around the world, including more than 30 million Americans, have diabetes. Obesity is the most significant risk factor for type 2 diabetes. yet about 30 percent of obese people do not develop type 2 diabetes or other metabolic conditions. New research aims to understand on a cellular level, how this separation occurs.READ MORE
Measuring hand grip can help identify youths who could benefit from lifestyle changes, says new research. While other studies have shown that muscle weakness as measured by grip strength is a predictor of unhealthy outcomes - including cardiovascular and metabolic diseases - this is the first to do so for adolescent health over time.READ MORE